Campbell & Co. Investment Adviser »

Ptc Therapeutics I shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-09-30 $376k 10k 37.10
2022-12-31 $517k 14k 38.17
2022-09-30 $1.1M 21k 50.21
2022-06-30 $374k 9.3k 40.08

More positions owned by Campbell & Co. Investment Adviser

Workday Common Stock (WDAY)
PepsiCo Common Stock (PEP)
Msci Common Stock (MSCI)
Amphenol Corp Common Stock (APH)
Everest Group Common Stock (EG)
Cognizant Technology Solutions Common Stock (CTSH)
Tenable Holdings Common Stock (TENB)
Marsh & McLennan Cos Common Stock (MMC)
Intercontinental Exchange Common Stock (ICE)
Allegion Common Stock (ALLE)
Maximus Common Stock (MMS)
Janus Henderson Group Common Stock (JHG)
Royal Bank of Canada Common Stock (RY)
Portland General Electric Common Stock (POR)
Equifax Common Stock (EFX)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Ptc Therapeutics I

Vanguard Group
BlackRock
BlackRock
Armistice Capital
Cowen And Company
Henderson Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Jacobs Levy Equity Management
D. E. Shaw & Co
Franklin Resources
Blackstone Group
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Ptc Therapeutics I